AIA
BIIB icon

Allegis Investment Advisors’s Biogen BIIB Stock Holding History

Allegis Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,007
Closed -$479K – 224
2016
Q2 		$479K Buy
2,007
+196
+11% +$51.7K 0.24% 125
2016
Q1 		$471K Buy
1,811
+249
+16% +$65.8K 0.27% 118
2015
Q4 		$479K Buy
+1,562
New +$449K 0.27% 104

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allegis Investment Advisors's BIIB Position: Q3 2016 in Review

Allegis Investment Advisors sold out of Biogen (BIIB) in Q3 2016, closing a stake of 2,007 shares — an estimated $479K sold.

Allegis Investment Advisors first reported a position in BIIB in Q4 2015 and held it in 3 quarters. The position peaked at $479K in Q2 2016. 1,012 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

  • Allegis Investment Advisors reported no remaining Biogen position as of Q3 2016 after selling out during the quarter.
  • Allegis Investment Advisors sold 2,007 Biogen shares in Q3 2016, an estimated $479K.
  • Allegis Investment Advisors first reported a position in Biogen in Q4 2015 and held it in 3 quarters.
  • Allegis Investment Advisors's Biogen position peaked at $479K in Q2 2016.
  • 1,012 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on Allegis Investment Advisors's 13F filing for Q3 2016, filed 3 Nov 2016.